APA

This interactive installation begs the question, “What is the truth of life with schizophrenia?”

What is the potential impact of social media overuse and mental health crises in young patients?

A look at 3 different psychiatric perspectives for successfully diagnosing ADHD in previously undiagnosed adults.

Explore treatment resistance at the 2024 APA Annual Meeting!

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

An expert gives us a preview of the clinical pearls clinicians can expect from his presentations at this year’s APA Annual Meeting.

Which is the best recommendation for the treatment of alcohol use disorder?

Don't miss these 2 APA Annual Meeting sessions on personality disorders!

We asked some of the presenters and attendees of the upcoming 2024 APA Annual Meeting what they were excited about. Here's what they said.

The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.

Our Editorial Board members are delivering expert perspectives on a wide variety of psychiatric issues and disorders.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

What are the cultural psychiatry perspectives on personality disorders? Don't miss this APA session!

Are you coming to the 2024 APA Annual Meeting? We'll see you there!

COVID-19 inspired researchers to devise new approaches to clinical trials.

How can trainees build and foster communities?

Poster at annual meeting highlighted the importance of equity, diversity, and inclusion (EDI) training in child and adolescent psychiatry.

Session at annual meeting discussed the importance cultivating diversity.

Mental health professionals should cry. Here's why.

Recognition is the first and most important step to treating behavioral and psychological symptoms of dementia.

Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression.

Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.

Psychiatric Times’ very own H. Steven Moffic, MD, spoke about resilience and religion at the 2023 APA Annual Meeting.

Experts discuss findings from a new trial exploring affect-focused psychotherapies for LGBTQ+ patients with PTSD at the 2023 APA Annual Meeting.

Learn more about women’s issues, suicide, and PTSD in the military.

An inside look at what treatments are being discussed in San Francisco...

How can religion impact resilience?

Session at the annual meeting discussed the importance of integrated care electives.

Data presents opportunities to enhance care and improve treatment adherence.